EverSource Wealth Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

EverSource Wealth Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.78K	Buy	298 +6	+2%	+$68	﹤0.01%	3393
2025 Q4	$2.39K	Sell	292 -3	-1%	-$35	﹤0.01%	3435
2025 Q3	$3.54K	Buy	295 +3	+1%	+$32	﹤0.01%	3298
2025 Q2	$2.96K	Buy	292 +183	+168%	+$1.23K	﹤0.01%	3355
2025 Q1	$608	Buy	+109	New	+$953	﹤0.01%	3397

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

EverSource Wealth Advisors's ORIC Position: Q1 2026 in Review

EverSource Wealth Advisors increased its Oric Pharmaceuticals (ORIC) stake by 2.1% in Q1 2026, buying an estimated $68 and bringing the position to 298 shares worth $3.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

EverSource Wealth Advisors first reported a position in ORIC in Q1 2025 and has held it in 5 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

EverSource Wealth Advisors held 298 shares of Oric Pharmaceuticals worth $3.78K as of Q1 2026.
EverSource Wealth Advisors bought 6 Oric Pharmaceuticals shares in Q1 2026, an estimated $68.
Oric Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3393 holding.
EverSource Wealth Advisors first reported a position in Oric Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.